Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease

Several treatment options are currently available to mitigate lacrimal system dysfunction in TED. More targeted therapies are emerging or have recently appeared in the clinic. Patients with mild TED can benefit from supportive care aimed at symptomatic relief. An inter-disciplinary approach to managing patients with lacrimal system abnormalities can minimize the impact of lacrimal insufficiency in TED.